Provision of medications to treat opioid use disorder via a mobile health unit: A scoping review
Authors:
- 7 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Substance Use and Addiction Treatment
- Vol. 164, 209431
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse
- National Institutes of Health
This publication has 48 references indexed in Scilit:
- Typology of laws restricting access to methadone treatment in the United States: A latent class analysisInternational Journal of Drug Policy, 2023
- Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to useDrug and Alcohol Dependence, 2021
- Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use DisorderJAMA Network Open, 2021
- Comparative Effectiveness of Different Treatment Pathways for Opioid Use DisorderJAMA Network Open, 2020
- Buprenorphine Treatment Divide by Race/Ethnicity and PaymentJAMA Psychiatry, 2019
- Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patientsDrug and Alcohol Dependence, 2018
- Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 yearsEuropean Journal of Pharmacology, 2018
- Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatmentContemporary Clinical Trials, 2017
- Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysisHepatology, 2013
- Patient retention in mobile and fixed-site methadone maintenance treatmentDrug and Alcohol Dependence, 1996